sarafotoxin S6c [7063]



sarafotoxin S6c


SMILES None
InChIKey None
Sequence CTCNDMTDEECLNFCHQDVIW
HELM PEPTIDE1{(C,[dC]).[*C(=O)C(C(C)O)N* |$_R2;;;;;;;;_R1$|].(C,[dC]).(N,[dN]).(D,[dD]).(M,[dM]).[*C(=O)C(C(C)O)N* |$_R2;;;;;;;;_R1$|].(D,[dD]).(E,[dE]).(E,[dE]).(C,[dC]).(L,[dL]).(N,[dN]).(F,[dF]).(C,[dC]).(H,[dH]).(Q,[dQ]).(D,[dD]).(V,[dV]).[*C(=O)C(C(C)CC)N* |$_R2;;;;;;;;;_R1$|].(W,[dW])}$PEPTIDE1,PEPTIDE1,3:R3-11:R3|PEPTIDE1,PEPTIDE1,1:R3-15:R3$$$V2.0

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Log P None
Molecular weight (Da) None


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

sarafotoxin S6c


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.